Key result
Long-acting nitroglycerin formulations, including intravenous, transdermal, and transmucosal options, offer a new era of rational and effective prophylaxis for angina.
Answers are grounded in this paper and cite their sources.
An editorial discussing the advent of long-acting nitroglycerin formulations for the prophylaxis of angina.
Editorials1 November 1982Long-Acting Nitroglycerin for Angina, 1982: Old Dog, New TricksNATHANIEL REICHEK, M.D., ST. JOHN SUTTON MARTIN, M.B.NATHANIEL REICHEK, M.D.Search for more papers by this author, ST. JOHN SUTTON MARTIN, M.B.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-97-5-774 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptTreatment of angina with nitroglycerin is more than 100 years old, but recent advances promise to revolutionize its use (1). With intravenous, long-acting transdermal and long-acting transmucosal nitroglycerin recently available, we stand on the threshold of an era of rational, effective nitroglycerin prophylaxis. To provide real benefits to patients, clinicians will have to use nitroglycerin more critically and systematically than in the past.The basic action of nitroglycerin is relaxation of vascular smooth muscle (2). The molecular mechanism of this action remains unclear. Although calcium flux may be altered, nitroglycerin is not similar in mechanism to nifedipine, verapamil, and diltiazem...References1. MURRELL W. Nitroglycerin as a remedy for angina pectoris. Lancet. 1979;1:284-92. Google Scholar2. MASONBRAUNWALD DE. The effects of nitroglycerin and amyl nitrite on anteriolar and venous tone in the human forearm. Circulation. 1965;32:755-66. CrossrefMedlineGoogle Scholar3. FLECKENSTEIN A. Specific pharmacology of calcium in myocardium, cardiac pacemakers, and vascular smooth muscle. Ann Rev Pharmacol Toxicol. 1977;17:149-66. CrossrefMedlineGoogle Scholar4. MCNIFFYACOBIYOUNG-CHANGGOLDENGOLDFARBFUNG EAFLAH. Pharmacokinetics of nitroglycerin after intravenous infusion in normal subjects. J Pharm Sci. 1981;70:1054-63. CrossrefMedlineGoogle Scholar5. BRACHFELDBOZERGORLIN NJR. Action of nitroglycerin on the coronary circulation in normal and in mild cardiac subjects. Circulation. 1959;19:697-704. CrossrefMedlineGoogle Scholar6. ZELISMASON RD. Demonstration of nitrite tolerance: attenuation of the venodilator response to nitroglycerin by the chronic administration of isosorbide dinitrate [Abstract]. Circulation. 1979;40(suppl III):221. Google Scholar7. WEBERJANICKI KJ. The metabolic demand and oxygen supply of the heart: physiological and clinical considerations. Am J Cardiol. 1979;44:722-9. CrossrefMedlineGoogle Scholar8. GANZMARCUS WH. Failure of intracoronary nitroglycerin to alleviate pacing-induced angina. Circulation. 1972;46:880-9. CrossrefMedlineGoogle Scholar9. GOLDSTEINROSINGREDWOODBEISEREPSTEIN RDDGS. Clinical and circulatory effects of isosorbide dinitrate: comparison with nitroglycerin. Circulation. 1971;43:629-40. CrossrefMedlineGoogle Scholar10. REDWOODROSINGGOLDSTEINBEISEREPSTEIN DDRGS. Importance of the design of an exercise protocol in the evaluation of patients with angina pectoris. Circulation. 1971;43:618-28. CrossrefMedlineGoogle Scholar11. REICHEKGOLDSTEINREDWOODEPSTEIN NRDS. Sustained effects of nitroglycerin ointment in patients with angina pectoris. Circulation. 1974;50:348-52. CrossrefMedlineGoogle Scholar12. DANAHYBURWELLARONOWPRAKASH DDWR. Sustained hemodynamic and antianginal effect of high dose oral isosorbide dinitrate. Circulation. 1977;55:381-7. CrossrefMedlineGoogle Scholar13. REICHEKPRIESTKINEZLEKLEVELANDBOLTONST. JOHN SUTTON NCMJSM. Angina prophylaxis with buccal synchron nitroglycerin: a rapid onset long-acting nitrate. In: BUSSMAN WD, DRIES RR, WAGNER W, eds. Advances in Pharmacotherapy; Vol 1: Controlled Release Nitroglycerin in Buccal and Oral Form. Bassel: S. Karger AG; 1982. Google Scholar14. NEEDLEMANLANGJOHNSON PSE. Organic nitrates: relationship between biotransformation and rational angina pectoris therapy. J Pharmacol Exp Ther. 1972;181:489-97. MedlineGoogle Scholar15. THADANIFUNGDARKEPARKER UHAJ. Oral isosorbide dinitrate in the treatment of angina pectoris: dose-response relationship and duration of action during acute therapy. Circulation. 1980;62:491-502. CrossrefMedlineGoogle Scholar16. THADANIFUNGDARKEPARKER UHAJ. Oral isosorbide dinitrate in angina pectoris: comparison of duration of action and dose-response relation during acute and sustained therapy. Am J Cardiol. 1982;49:411-9. CrossrefMedlineGoogle Scholar17. DAVISWIESEL JB. The treatment of angina pectoris with a nitroglycerin ointment. Am J Med. 1955;21:230-59. Google Scholar18. HANSENWOODSWILLS MSR. Relative effectiveness of nitroglycerin ointment according to site of application. Heart Lung. 1979;8:716-20. MedlineGoogle Scholar19. REICHEKPRIESTST. JOHN SUTTON NCM. Long-term buccal administration of synchron nitroglycerin. In: BUSSMAN WD, DRIES RR, WAGNER W, eds. Advances in Pharmacotherapy; Vol. 1: Controlled Release Nitroglycerin in Buccal and Oral Form. Basel: S Karger AG; 1982. Google Scholar20. LICHSTEINGREENGARTBOLTONHOLLANDERSANDERS EASGM. Efficacy of buccal synchron nitroglycerin in patients with angina pectoris. In: BUSSMAN WD, DRIES RR, WAGNER W, eds. Advances in Pharmacotherapy; Vol. 1: Controlled Release Nitroglycerin in Buccal and Oral Form. Basel: S Karger AG; 1982. Google Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAffiliations: Department of Medicine Hospital of the University of Pennsylvania Philadelphia, Pennsylvania PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited ByRecent developments in nitrate therapy of ischaemic heart diseaseExperience with Intrainstitutional Clinical Evaluations of Newly Marketed Preparations as a Basis for Drug-Product Selection to Hospital FormulariesPharmacology of the nitrates in angina pectorisFailure of transdermal nitroglycerin to improve exercise capacity in patients with angina pectorisTreatment of Ischemic Digital Ulcers with Nitroglycerin OintmentNitroglycerin and long-acting nitrates in clinical practiceBuccal Nitroglycerin 1 November 1982Volume 97, Issue 5Page: 774-776KeywordsAnginaCalciumProphylaxisSmooth muscles Issue Published: 1 November 1982 PDF DownloadLoading ...
No takes yet. Share an insight, caveat, or question.
Nathaniel Reichek (1982) conducted an editorial in Angina. Long-acting nitroglycerin was evaluated. Long-acting nitroglycerin formulations, including intravenous, transdermal, and transmucosal options, offer a new era of rational and effective prophylaxis for angina.
Synapse has enriched 10 related papers. Consider them for comparative context: